Summary of NICE guidance for Golimumab / Romiplostim / Psychosis with substance misuse / Opioid detoxification

Karoline Brennan, Senior Medicines Information Pharmacist, North West Medicines Information CentreSource North West Medicines Information CentrePublished

This edition of NICE Bites reflects current NICE guidance (as at November 2020). Please go to NICE to check for any recent updates to this guideline.

NICE Bites is a monthly bulletin which summarises key prescribing points from NICE guidance. NICE Bites No 30, May 2011 includes the following topics:

Golimumab for the treatment of psoriatic arthritis (NICE TA220),

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (NICE TA221),

Psychosis with coexisting substance misuse (NICE CG120),

Drug misuse: Opioid detoxification (NICE CG52).

Attachments